Loading...

PE anti-mouse CD45 Antibody

Pricing & Availability
Clone
30-F11 (See other available formats)
Regulatory Status
RUO
Other Names
T200, Ly-5, LCA
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
a-30-F11_PE_090507
C57BL/6 mouse splenocytes stained with 30-F11 PE
  • a-30-F11_PE_090507
    C57BL/6 mouse splenocytes stained with 30-F11 PE
  • b-30-F11_PE_CD45_Antibody_2_041922
    C57BL/6 mouse splenocytes were stained with CD45 (clone 30-F11) PE (solid line) or rat IgG2b, κ PE isotype control (dashed line).

    Data was acquired on the Moxi Flow, exported, and processed using FlowJo software.
Compare all formats See PE spectral data
Cat # Size Price Save
103105 50 µg ¥9,680
103106 200 µg ¥18,920
Description

CD45 is a 180-240 kD glycoprotein also known as the leukocyte common antigen (LCA), T200, or Ly-5. It is a member of the protein tyrosine phosphatase (PTP) family, expressed on all hematopoietic cells except mature erythrocytes and platelets. There are different isoforms of CD45 that arise from variable splicing of exons 4, 5, and 6, which encode A, B, and C determinants, respectively. CD45 plays a key role in TCR and BCR signal transduction. These isoforms are very specific to the activation and maturation state of the cell as well as cell type. The primary ligands for CD45 are galectin-1, CD2, CD3, CD4, TCR, CD22, and Thy-1.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
Mouse thymus or spleen
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
Concentration
0.2 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
Application Notes

Clone 30-F11 reacts with all isoforms and both CD45.1 and CD45.2 alloantigens of CD45.

Additional reported applications (for relevant formats) include: immunoprecipitation3, complement-dependent cytotoxicity1,5, immunohistochemistry (acetone-fixed frozen sections, zinc-fixed paraffin-embedded sections and formalin-fixed paraffin-embedded sections)4,6, Western blotting7, and spatial biology (IBEX)10,11. The Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) is recommended for functional assays (Cat. No. 103163 and 103164).

Application References

(PubMed link indicates BioLegend citation)
  1. Podd BS, et al. 2006. J. Immunol. 176:6532. (FC, CMCD) PubMed
  2. Haynes NM, et al. 2007. J. Immunol. 179:5099. (FC)
  3. Ledbetter JA, et al. 1979. Immunol. Rev. 47:63. (IP)
  4. Simon DI, et al. 2000. J. Clin. Invest. 105:293. (IHC)
  5. Seaman WE. 1983. J. Immunol. 130:1713. (CMCD)
  6. Cornet A, et al. 2001. P. Natl. Acad. Sci. USA 98:13306. (IHC)
  7. Tsuboi S and Fukuda M. 1998. J. Biol. Chem. 273:30680. (WB) PubMed
  8. Liu F, et al. 2012. Blood. 119:3295. PubMed
  9. Pelletier AN, et al. 2012. J. Immunol. 188:5561. PubMed
  10. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  11. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  2. Chan LC, et al. 2019. J Clin Invest. 129:3324. PubMed
  3. Khorooshi R, et al. 2020. Acta Neuropathol Commun. 8:02. PubMed
  4. Kimura S, et al. 2020. Nat Commun. 0.620833333. PubMed
  5. Frieler RA, et al. 2017. Exp Neurol. 298:104. PubMed
  6. Djokić V, et al. 2019. Front Immunol. 9:2891. PubMed
  7. Hepler C et al. 2017. eLife. 6 pii: e27669. PubMed
  8. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  9. Liu K, et al. 2021. Cell Metabolism. 33(3):666-675.e4. PubMed
  10. Vercauteren Drubbel A, et al. 2021. Cell Stem Cell. . PubMed
  11. Linden J, et al. 2020. J Interferon Cytokine Res. 40:292. PubMed
  12. Ramos SA, et al. 2022. J Allergy Clin Immunol. 149:767. PubMed
  13. Friesen M, et al. 2022. Brain Pathol. 32:e13032. PubMed
  14. Kang H, et al. 2022. Adv Mater. 34:e2106500. PubMed
  15. Brandt KJ, et al. 2022. Int J Mol Sci. 23: . PubMed
  16. Cha JH, et al. 2022. J Biol Chem. 298:101817. PubMed
  17. Cox MJ, et al. 2022. Leukemia. 36:1635. PubMed
  18. Yu C, et al. 2022. Invest Ophthalmol Vis Sci. 63:1. PubMed
  19. Grégoire C, et al. 2022. Immunity. 55:1216. PubMed
  20. Liu X, et al. 2022. Chin Med J (Engl). 135:1821. PubMed
  21. Zhang X, et al. 2022. EBioMedicine. 84:104275. PubMed
  22. Dedousis N, et al. 2022. J Lipid Res. 63:100284. PubMed
  23. Yang J, et al. 2022. Mol Ther Nucleic Acids. 30:184. PubMed
  24. Hirano K, et al. 2023. Life Sci Alliance. 6: . PubMed
  25. Ding L, et al. 2023. J Clin Invest. 133: . PubMed
  26. Al-Saafeen BH, et al. 2023. Front Immunol. 13:1017780. PubMed
  27. Montilla A, et al. 2023. Cell Death Dis. 14:16. PubMed
  28. Smith LA, et al. 2023. Front Oncol. 12:1031174. PubMed
  29. Gonçalves R, et al. 2023. iScience. 26:105972. PubMed
  30. Wang Y, et al. 2023. FASEB J. 37:e22776. PubMed
  31. Tanaka T, et al. 2023. Nat Immunol. 24:439. PubMed
  32. Wang R, et al. 2023. iScience. 26:105954. PubMed
  33. Vuerich R, et al. 2023. NPJ Regen Med. 8:8. PubMed
  34. Tan Y, et al. 2023. NPJ Regen Med. 8:7. PubMed
  35. Masuda H, et al. 2022. MAbs. 14:2122275. PubMed
  36. Shi H, et al. 2022. Nutrients. 14:. PubMed
  37. Peng W, et al. 2022. Cell Mol Life Sci. 79:602. PubMed
  38. Elbasiony E, et al. 2023. NPJ Aging. 9:2. PubMed
  39. Pioli KT, et al. 2023. iScience. 26:106223. PubMed
  40. Dang YZ, et al. 2023. Neoplasma. 70:123. PubMed
  41. Palakurthi B, et al. 2023. Nat Commun. 14:2109. PubMed
  42. Shen Z, et al. 2023. iScience. 26:106572. PubMed
  43. Abdelwahab T, et al. 2023. iScience. 26:106698. PubMed
  44. Kretschmer I, et al. 2016. J Biol Chem. 291: 4091 - 4106. PubMed
  45. Xin G, et al. 2021. Cancer Immunol Res. 9:454. PubMed
  46. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  47. d'Errico P, et al. 2021. Nat Neurosci. Online ahead of print. PubMed
  48. Hagan N, et al. 2020. Cell Death Dis. 1.086111111. PubMed
  49. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  50. Wu N, et al. 2020. Cell Rep. 30:1129. PubMed
  51. Abels ER et al. 2019. Cell Rep. 28(12):3105-3119 . PubMed
  52. Afolabi LO, et al. 2021. Front Immunol. 12:701671. PubMed
  53. Sun D, et al. 2021. Cell Stem Cell. . PubMed
  54. Furuta Y, et al. 2017. PLoS One. 12(2):e0172509. PubMed
  55. Weng L, et al. 2016. Sci Rep. 6:38632. PubMed
  56. Riley JS, et al. 2020. Blood Adv. 4:1102. PubMed
  57. Karlen SJ, et al. 2018. J Neuroinflammation. 15:344. PubMed
  58. Cieslik KA, et al. 2018. J Gerontol A Biol Sci Med Sci. 73:1167. PubMed
  59. Kobayashi Y, et al. 2018. PLoS One. 13:e0195008. PubMed
  60. Chen J, et al. 2021. Sci Adv. 7:. PubMed
  61. Rodriguez-García A, et al. 2021. Nat Commun. 12:877. PubMed
  62. Maimets M, et al. 2016. Stem Cell Reports. 6:150-162. PubMed
  63. Tilstam PV, et al. 2021. J Clin Invest. 131:. PubMed
  64. Catrina AM, et al. 2021. Rom J Morphol Embryol. 62:109. PubMed
  65. Wei H, et al. 2020. Cell Death Dis. 11:290. PubMed
  66. Ogawa M, et al. 2019. J Biol Methods. 5:e102. PubMed
  67. Shmeleva EV, et al. 2019. Front Immunol. 10:1780. PubMed
  68. Jenull S, et al. 2021. Cell Reports. 36(3):109406. PubMed
  69. Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed
  70. Shu T, et al. 2022. Eur Respir J. Online ahead of print. PubMed
  71. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  72. Glaubitz J, et al. 2022. Nat Commun. 13:4502. PubMed
  73. Sun Q, et al. 2022. Cell Death Dis. 13:724. PubMed
  74. Rafiq S, et al. 2018. Nat Biotechnol. 36:847. PubMed
  75. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  76. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  77. Joseph R, et al. 2021. Br J Cancer. 125:176. PubMed
  78. Wang Y, et al. 2021. Nat Commun. 12:2343. PubMed
  79. Galle E, et al. 2022. Genome Biol. 23:207. PubMed
  80. Aoki H, et al. 2009. Development. 136:2511. PubMed
  81. Guha S, et al. 2014. Brain Behav Immun. 11:123. PubMed
  82. Ogawa-Wong A, et al. 2022. Metabolites. 12:. PubMed
  83. Hongu T, et al. 2022. Nat Cancer. 3:486. PubMed
  84. An YA et al. 2017. eLife. 6 pii: e24071. PubMed
  85. Meixiong J et al. 2019. Immunity. 50(5):1163-1171 . PubMed
  86. Cao W, et al. 2017. Immunity. 47:1182. PubMed
  87. Hsu JM, et al. 2018. Nat Commun. 9:1908. PubMed
  88. Endo Y, et al. 2020. FASEB J. 34:16086. PubMed
  89. Serrano Martinez P, et al. 2022. iScience. 25:105047. PubMed
  90. An J, et al. 2022. iScience. 25:103570. PubMed
  91. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  92. Hillel–Karniel C, et al. 2020. Cell Reports. 30(3):807-819.e4.. PubMed
  93. He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed
  94. Green DP, et al. 2019. Neuron. 101:412. PubMed
  95. Dumas AA, et al. 2020. EMBO J. 39:e103790. PubMed
  96. Fontana D, et al. 2020. Hemasphere. e497:4. PubMed
  97. Vijay R, et al. 2015. J Exp Med. 212: 1851 - 1868. PubMed
  98. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  99. Miska J et al. 2019. Cell reports. 27(1):226-237 . PubMed
  100. Wang GZ, et al. 2019. Nat Commun. 10:1125. PubMed
  101. Chen X et al. 2017. Cell stem cell. 21(6):747-760 . PubMed
  102. Chang CS, et al. 2022. iScience. 25:103738. PubMed
  103. Sinha VC, et al. 2021. Nat Commun. 12:5024. PubMed
  104. Formaglio P, et al. 2021. Immunity. 54:2724. PubMed
  105. Hu J, et al. 2022. J Neuroinflammation. 19:71. PubMed
  106. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  107. Oliver J, et al. 2009. J Am Soc Nephrol. 2.440972222. PubMed
  108. Sardella C, et al. 2018. J Invest Dermatol. 138:500. PubMed
  109. Yang Z, et al. 2020. Sci Rep. 17757:10. PubMed
  110. Socodato R, et al. 2020. Sci Signal. 13: . PubMed
  111. Marinescu CI, et al. 2021. Stem Cell Res Ther. 12:319. PubMed
  112. Slezak AJ, et al. 2022. ACS Cent Sci. 8:1435. PubMed
  113. Yu Y, et al. 2022. Nat Commun. 13:6857. PubMed
  114. Mencarelli A, et al. 2016. Sci Rep. 6:30802. PubMed
  115. Bauer T, et al. 2021. Life (Basel). 11:. PubMed
  116. Ye P, et al. 2022. Front Cardiovasc Med. 8:810477. PubMed
  117. Ebrahimi-Nik H, et al. 2021. Nat Commun. 12:6423. PubMed
  118. Khatib–Massalha E, et al. 2020. Nat Commun. 2.921527778. PubMed
  119. Chauveau A, et al. 2020. Immunity. 52:794. PubMed
  120. Qi S et al. 2016. eLife. 5 pii: e14756. PubMed
  121. Wilson DH, et al. 2020. Nat Commun. 0.767361111. PubMed
  122. Fang Y, et al. 2019. Aging (Albany NY). 11:4910. PubMed
  123. Barker KA, et al. 2021. Journal of Clinical Investigation. 131(11):. PubMed
  124. Ito T, et al. 2021. Commun Biol. 4:694. PubMed
  125. Olson M, et al. 2014. J Immunol. 193:5420. PubMed
  126. Sun H, et al. 2022. Front Immunol. 13:818017. PubMed
  127. Simula L et al. 2018. Cell reports. 25(11):3059-3073 . PubMed
  128. Chen Z, et al. 2019. J Exp Med. 216:152. PubMed
  129. Wang QA et al. 2018. Cell metabolism. 28(2):282-288 . PubMed
  130. Khare P, et al. 2017. J Autoimmun. 10.1016/j.jaut.2017.09.002. PubMed
  131. Feng J,et al. 2017. Nat Commun. . 10.1038/s41467-017-01056-8. PubMed
  132. Douam F, et al. 2017. Mbio. 10.1128/mBio.00819-17. PubMed
  133. Liu X, et al. 2020. Cell Host Microbe. 28(5):683-698.e6. PubMed
  134. Walsh SM, et al. 2021. eLife. 10:00. PubMed
  135. Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed
  136. Meng X, et al. 2022. Proc Natl Acad Sci U S A. 119:. PubMed
  137. Hu M, et al. 2020. Cancer Immunol Res. 8:1150. PubMed
  138. Kitajima Y, et al. 2022. Cells. 11:. PubMed
  139. Wijewarnasuriya D, et al. 2020. Cancer Immunol Res. 0.841666667. PubMed
  140. Bota-Rabassedas N, et al. 2021. Cell Reports. 35(3):109009. PubMed
  141. Li Y, Kaneda T 2016. Sci Rep. 6: 25077. PubMed
  142. McCallion A, et al. 2022. Front Immunol. 13:961599. PubMed
  143. Matsumoto A, et al. 2021. iScience. 24:102839. PubMed
  144. Lee-Chang C, et al. 2021. J Exp Med. 218:. PubMed
  145. Wang W, et al. 2021. J Am Heart Assoc. 10:e019142. PubMed
  146. Dulken BW, et al. 2019. Nature. 571:205. PubMed
  147. Kamata T, et al. 2020. Cell Reports. 31(12):107802. PubMed
  148. Senthil K, et al. 2021. Invest Ophthalmol Vis Sci. 62:38. PubMed
  149. Li Z, et al. 2022. Nat Commun. 13:6321. PubMed
  150. Dholakia J, et al. 2022. Gynecol Oncol. 164:170. PubMed
  151. Wang Y, et al. 2022. Front Immunol. 13:847581. PubMed
  152. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  153. Dhar P, et al. 2021. Commun Biol. 4:905. PubMed
  154. Kronborg Hansen AK, et al. 2022. Int J Mol Sci. 23:. PubMed
  155. Liu X, et al. 2021. Int J Med Sci. 18:3125. PubMed
  156. Song E, et al. 2020. Nature. 577:689. PubMed
  157. Canedo T, et al. 2021. Neuropsychopharmacology. 46:2358. PubMed
  158. Ma L, et al. 2022. Sci Adv. 8:eabm3470. PubMed
  159. Milon B, et al. 2021. Cell Rep. 36:109758. PubMed
  160. Liu B, et al. 2013. Development. 140:780. PubMed
  161. Bao Z, et al. 2020. Ann Transplant. 25:e921287. PubMed
  162. Montel‐Hagen A et al. 2019. Cell stem cell. 24(3):376-389 . PubMed
  163. Zhao N, et al. 2018. J Clin Invest. 26:84. PubMed
  164. Dieu RS, et al. 2021. Front Neurosci. 15:685645. PubMed
  165. Zhang Y, et al. 2021. Commun Biol. 344:4. PubMed
  166. Liao Y, et al. 2020. Theranostics. 7.113888889. PubMed
  167. Watson N, et al. 2015. J Immunol. 194:2796. PubMed
  168. Wang X, et al. 2021. Inflammation. 44:1815. PubMed
  169. Genoud V, et al. 2018. Oncoimmunology. 7:e1501137. PubMed
  170. Xu L, et al. 2019. Haematologica. 10.3324/haematol.2018.207258. PubMed
  171. Korin B, et al. 2020. Sleep. :43. PubMed
  172. An X, et al. 2020. Thyroid. . PubMed
  173. Sanz-Ros J, et al. 2022. Sci Adv. 8:eabq2226. PubMed
  174. Singhal P, et al. 2016. Proc Natl Acad Sci U S A. 113: 122 - 127. PubMed
  175. Bollinger JL, et al. 2020. Neuropsychopharmacology. 45:1766. PubMed
  176. Yue F, et al. 2022. Cell Rep. 38:110267. PubMed
  177. Andreou T, et al. 2021. J Immunother Cancer. 9:. PubMed
  178. Nakao M, et al. 2021. Sci Rep. 11:18384. PubMed
  179. Srivastava S, et al. 2020. Cancer Cell. 39(2):193-208.e10. PubMed
  180. Lau A, et al. 2022. Sci Adv. 8:eabm0142. PubMed
  181. Hung G, et al. 2022. NPJ Aging. 8:10. PubMed
  182. Gawish R, et al. 2022. Elife. 11:. PubMed
  183. Wen G, et al. 2018. J Am Heart Assoc. 7:e008187. PubMed
  184. Stone S et al. 2018. Glia. 66(7):1331-1345 . PubMed
  185. Gardenier J, et al. 2017. Nat Commun. 8:14345. PubMed
  186. Singh K, et al. 2021. Front Immunol. 640837:12. PubMed
  187. Orhon I, et al. 2021. Autophagy. :1. PubMed
  188. Szõke D, et al. 2021. Nat Commun. 12:3460. PubMed
  189. Kojima T, et al. 2016. Sci Rep. 6:36457. PubMed
  190. Lehmann M, et al. 2020. Cell Signal. 70:109588. PubMed
  191. Cugurra A, et al. 2021. Science. 373:. PubMed
  192. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  193. Engelmann R, et al. 2017. J Negat Results Biomed. 16:05. PubMed
  194. Tong Y, et al. 2018. EBioMedicine. 39:132. PubMed
  195. Lehmann ML, et al. 2018. Sci Rep. 8:11240. PubMed
  196. Lupan AM, et al. 2021. Aging (Albany NY). 13:15875. PubMed
  197. Li J, et al. 2021. eLife. 10:00. PubMed
  198. Simula L, et al. 2020. Cell Death Differ. 27:2749. PubMed
RRID
AB_312970 (BioLegend Cat. No. 103105)
AB_312971 (BioLegend Cat. No. 103106)

Antigen Details

Structure
Protein tyrosine phosphatase (PTP) family, 180-240 kD
Distribution

All hematopoietic cells except mature erythrocytes and platelets

Function
Phosphatase, T and B cell activation
Ligand/Receptor
Galectin-1, CD2, CD3, CD4, TCR, CD22, Thy-1
Cell Type
B cells, Dendritic cells, Mesenchymal Stem Cells, Tregs
Biology Area
Cell Biology, Immunology, Inhibitory Molecules, Innate Immunity, Neuroscience, Neuroscience Cell Markers, Stem Cells
Molecular Family
CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Trowbridge IS, et al. 1993. Annu. Rev. Immunol. 12:85.
3. Kishihara K, et al. 1993. Cell 74:143.
4. Pulido R, et al. 1988. J. Immunol. 140:3851.

Gene ID
19264 View all products for this Gene ID
UniProt
View information about CD45 on UniProt.org

Related FAQs

What type of PE do you use in your conjugates?
We use R-PE in our conjugates.

Other Formats

View All CD45 Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse CD45 30-F11 FC
Biotin anti-mouse CD45 30-F11 FC
FITC anti-mouse CD45 30-F11 FC
PE anti-mouse CD45 30-F11 FC
PE/Cyanine5 anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 30-F11 FC,IHC-F,CyTOF®,IP,CMCD,IHC,WB
PE/Cyanine7 anti-mouse CD45 30-F11 FC
APC/Cyanine7 anti-mouse CD45 30-F11 FC
Alexa Fluor® 488 anti-mouse CD45 30-F11 FC,SB
Alexa Fluor® 647 anti-mouse CD45 30-F11 FC,ICC,IHC,3D IHC,SB
Pacific Blue™ anti-mouse CD45 30-F11 FC
Alexa Fluor® 700 anti-mouse CD45 30-F11 FC,SB
PerCP/Cyanine5.5 anti-mouse CD45 30-F11 FC
PerCP anti-mouse CD45 30-F11 FC
Alexa Fluor® 594 anti-mouse CD45 30-F11 IHC-F,FC,3D IHC
Brilliant Violet 421™ anti-mouse CD45 30-F11 FC,SB
Brilliant Violet 570™ anti-mouse CD45 30-F11 FC
Brilliant Violet 510™ anti-mouse CD45 30-F11 FC
Brilliant Violet 605™ anti-mouse CD45 30-F11 FC
Purified anti-mouse CD45 (Maxpar® Ready) 30-F11 FC,CyTOF®
PE/Dazzle™ 594 anti-mouse CD45 30-F11 FC
Brilliant Violet 711™ anti-mouse CD45 30-F11 FC
Brilliant Violet 785™ anti-mouse CD45 30-F11 FC
Brilliant Violet 650™ anti-mouse CD45 30-F11 FC
APC/Fire™ 750 anti-mouse CD45 30-F11 FC
Brilliant Violet 750™ anti-mouse CD45 30-F11 FC
TotalSeq™-A0096 anti-mouse CD45 30-F11 PG
TotalSeq™-B0096 anti-mouse CD45 30-F11 PG
Ultra-LEAF™ Purified anti-mouse CD45 30-F11 FC,CyTOF®,IP,CMCD,IHC,WB
Spark Blue™ 550 anti-mouse CD45 30-F11 FC
Spark NIR™ 685 anti-mouse CD45 30-F11 FC
TotalSeq™-C0096 anti-mouse CD45 30-F11 PG
Spark YG™ 570 anti-mouse CD45 30-F11 IHC-F
PE/Fire™ 640 anti-mouse CD45 30-F11 FC
APC/Fire™ 810 anti-mouse CD45 30-F11 FC
PE/Fire™ 700 anti-mouse CD45 30-F11 FC
Spark Violet™ 538 anti-mouse CD45 30-F11 FC
Spark YG™ 593 anti-mouse CD45 30-F11 FC
Spark Blue™ 574 anti-mouse CD45 Antibody 30-F11 FC
Spark Blue™ 515 anti-mouse CD45 30-F11 FC
Spark UV™ 387 anti-mouse CD45 30-F11 FC
PE/Fire™ 810 anti-mouse CD45 30-F11 FC
Spark PLUS UV395™ anti-mouse CD45 30-F11 FC
Spark Red™ 718 anti-mouse CD45 30-F11 FC
Go To Top Version: 2    Revision Date: 05/14/2013

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account